EagleClaw Capital Managment LLC Acquires 180 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

EagleClaw Capital Managment LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,380 shares of the medical equipment provider’s stock after buying an additional 180 shares during the quarter. EagleClaw Capital Managment LLC’s holdings in Intuitive Surgical were worth $1,242,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $31,000. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at $36,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Bernstein Bank increased their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. Finally, JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 5.2 %

Shares of ISRG stock opened at $538.57 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm’s 50 day moving average price is $571.70 and its two-hundred day moving average price is $530.95. The stock has a market cap of $191.83 billion, a price-to-earnings ratio of 84.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,090 shares of company stock valued at $7,496,119. 0.90% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.